Infections in Rheumatology
SIG convenors: Dr Muddassir Shaikh, Dr Graham Raftery
Contact email: firstname.lastname@example.org
TheSIG focusses on Infections in Rheumatology. Rheumatology has many pertinentinfection related issues. Immunosuppressant agents including the biologictherapies have transformed the management of various rheumatological conditions;however infection in immunocompromised patients is a major concern. Infectivepathologies may manifest with musculoskeletal presentations and infections arealso implicated in the development of autoimmune conditions. The group is multidisciplinary including microbiologists, infectiousdisease physicians, immunologists, radiologists, orthopaedic surgeons, inaddition to rheumatologists interested in the advancement of our understandingof the pathology and management of above aspects.
ThisSIG provides a focussed forum for discussion on Infections in Rheumatology forclinical, educational and research purposes. Some of the objectives andactivities which we envisage for this SIG are:
Aforum for educational activity
Meetings will be held at the BSRRheumatology annual conference. Anyone with an interest in the area is welcometo attend the meetings. Thiswill also offer the general Rheumatologists the opportunity to broaden theirknowledge base in this field and keep abreast of the latest developments.
Webelieve any forum on Infections in Rheumatology requires multi-disciplinarycross speciality input. In recent years, we have established close links withnational experts in the fields of Microbiology, Infectious diseases,Orthopaedics, Musculoskeletal radiology and Nuclear medicine. Input from theseexperts would be invaluable not just for delivering an effective educationalsession but also for working on projects requiring cross-specialtycollaboration.
Researchactivity and clinical guidelines
TheSIG would be an ideal forum to promote collaborative research. We would seek toform close links with BSR Biologics Registers as well as the many researchgroups exploring the link between infection and autoimmunity. We would be keento be involved with the BSR and BHPR Standards, Guidelines and Audit WorkingGroup on relevant guidelines produced.